Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
SPANCRETE, Oct-Dec (3Q) Ordinary Profit Loss Widens
5277 SPANCRETE CORPORATION 【J-GAAP】
Earnings ReportSPANCRETE CORPORATION <5277> [TSE Std] announced its financial results after the market closed on February 14th (16:30). The ordinary loss (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2025 (April to December) was a reduced loss of 200 million yen (compared to a loss of 259 million yen in the previous period).
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the ordinary loss for the January to March period (4Q) is expected to expand to a loss of 290 million yen (compared to a loss of 46 million yen in the previous period).
In the most recent three-month period, from October to December (3Q), the ordinary loss expanded to a loss of 67 million yen (compared to a loss of 33 million yen in the previous period). The operating profit/loss margin drastically worsened from -7.0% in the same period last year to -19.5%.
Note: Since the current fiscal year, the company has transitioned to non-consolidated financial statements.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Apr - Dec, 2022 | 1,640 | -301 | -297 | -277 | -37.3 | ー | Feb 13, 2023 | J-GAAP |
Apr - Dec, 2023 | 1,499 | -269 | -259 | -257 | -34.6 | ー | Feb 13, 2024 | J-GAAP |
Apr - Dec, 2024 | 1,080 | -208 | -200 | -248 | -33.5 | ー | Feb 14, 2025 | J-GAAP |
YoY | -28.0% | +22.7% | +22.8% | +3.5% | +3.2% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Mar, 2023 | 1,020 | -88 | -79 | -72 | -9.7 | 0 | May 13, 2024 | J-GAAP |
Oct - Mar, 2024 Guidance | 627 | -354 | -357 | -383 | -51.6 | 0 | Nov 12, 2024 | J-GAAP |
YoY | -38.5% | -302.3% | -351.9% | -431.9% | -431.9% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar, 2023 | 2,268 | -511 | -504 | -548 | -73.6 | 0 | May 15, 2023 | J-GAAP |
Mar, 2024 | 2,035 | -323 | -305 | -301 | -40.5 | 0 | May 13, 2024 | J-GAAP |
Mar, 2025 Guidance | 1,353 | -493 | -490 | -539 | -72.6 | 0 | Aug 9, 2024 | J-GAAP |
YoY | -33.5% | -52.6% | -60.7% | -79.1% | -79.1% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Oct - Dec, 2023 | 484 | -34 | -33 | -28 | -3.8 | -7.0 | Feb 13, 2024 | J-GAAP |
Jan - Mar, 2024 | 536 | -54 | -46 | -44 | -5.9 | -10.1 | May 13, 2024 | J-GAAP |
Apr - Jun, 2024 | 372 | -55 | -52 | -61 | -8.3 | -14.8 | Aug 9, 2024 | J-GAAP |
Jul - Sep, 2024 | 354 | -84 | -81 | -95 | -12.9 | -23.7 | Nov 12, 2024 | J-GAAP |
Oct - Dec, 2024 | 354 | -69 | -67 | -92 | -12.4 | -19.5 | Feb 14, 2025 | J-GAAP |
YoY | -26.9% | -102.9% | -103.0% | -228.6% | -229.4% |
Related Articles
MRT, Returning to Profitability This Year
KENKO Mayonnaise, Oct-Dec (3Q) Ordinary Profit Decreases by 10%
EM SYSTEMS, 39% Decrease in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 6 yen, Plan to Continue the 35 yen Policy This Fiscal Year as Well
EduLab, Oct-Dec (1Q) Ordinary Profit Turns to Profit, Exceeds Full-Year Plan
SIOS, 15% Decrease in Ordinary Profit for The Current Fiscal Year
RS Technologies, 6% Increase in Ordinary Profit, Update Record High for Second Consecutive Term, Dividend Raised by 5 yen
Cyfuse Biomedical, The Current Fiscal Year's Net Income to Widen
SUS, Oct-Dec (1Q) Ordinary Profit Increases by 71%
COPRO-HOLDINGS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 46%, Oct-Dec Ordinary Profit Increases by 35%
Kitahama Capital Partners, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens